Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
new decrease » nn decrease (Expand Search), we decrease (Expand Search), teer decrease (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
new decrease » nn decrease (Expand Search), we decrease (Expand Search), teer decrease (Expand Search)
-
141
-
142
-
143
-
144
-
145
-
146
-
147
-
148
Evogliptin attenuates the phenotypic switch of VSMCs during CER treatment by decreasing the osteogenesis-associated genes <i>in-vitro.</i>
Published 2025“…(B, C) Summarized bar graph showed EVO significantly decreased calcium deposition and calcium content in CER treated P<sub>i</sub>-induced VSMCs. …”
-
149
-
150
Table 2_Bibliometric analysis of global research on the clinical applications of aminoglycoside antibiotics: improving efficacy and decreasing risk.docx
Published 2025“…Avoiding prolonged dosing cycles and refraining from using AGs in patients with the m.1555 A > G gene variant can significantly mitigate the risk of ototoxicity. Future studies should examine the pharmacokinetic and pharmacodynamic targets of AGs and assess the efficacy and safety of administration by inhalation to improve efficacy and decrease risk.…”
-
151
Table 1_Bibliometric analysis of global research on the clinical applications of aminoglycoside antibiotics: improving efficacy and decreasing risk.docx
Published 2025“…Avoiding prolonged dosing cycles and refraining from using AGs in patients with the m.1555 A > G gene variant can significantly mitigate the risk of ototoxicity. Future studies should examine the pharmacokinetic and pharmacodynamic targets of AGs and assess the efficacy and safety of administration by inhalation to improve efficacy and decrease risk.…”
-
152
-
153
Summary of post-treatment disease course measures from MDMA-AT publications.
Published 2025Subjects: -
154
-
155
Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications.
Published 2025Subjects: -
156
-
157
-
158
-
159
Summary of post-treatment disease course measures from off-label medications clinical trials.
Published 2025Subjects: -
160
Summary of post-treatment CAPS score changes from clinical trials with psychotherapies.
Published 2025Subjects: